{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:09:43Z","timestamp":1769580583065,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bayer Pharma AG"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jsbmb.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T13:01:58Z","timestamp":1376485318000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens"],"prefix":"10.1016","volume":"138","author":[{"given":"Fernand","family":"Labrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"B\u00e9rub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonello","family":"Cusan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Luis","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2013.08.002_bib0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e3181e195a6","article-title":"Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary","volume":"18","author":"Labrie","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","article-title":"Women's voices in the menopause: results from an international survey on vaginal atrophy","volume":"67","author":"Nappi","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/jwh.2008.1281","article-title":"Vaginal estrogen therapy for the treatment of atrophic vaginitis","volume":"18","author":"Lynch","year":"2009","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0030","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06264","article-title":"Is dehydroepiandrosterone a hormone","volume":"187","author":"Labrie","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/gme.0b013e31819e8930","article-title":"Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"111","author":"Labrie","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsbmb.2008.09.007","article-title":"Corrigendum to effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"112","author":"Labrie","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2013.08.002_bib0055","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1111\/j.1743-6109.2011.02523.x","article-title":"Dehydroepiandrosterone (DHEA)\u2014a precursor steroid or an active hormone in human physiology","volume":"8","author":"Traish","year":"2011","journal-title":"J. Sex Med."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0060","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/gme.0b013e31819e8e2d","article-title":"Intravaginal dehydroepiandrosterone (prasterone), a physiological and highly efficient treatment of vaginal atrophy","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/gme.0b013e31819e85c6","article-title":"Effect of intravaginal dehydroepiandrosterone (prasterone) on libido and sexual dysfunction in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0080","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"4","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4 Pt 1","key":"10.1016\/j.jsbmb.2013.08.002_bib0085","first-page":"584","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society","volume":"15","author":"Utian","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0090","series-title":"Guidance For Industry, Labeling Guidance for Noncontraceptive Estrogen Drug Products for the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms\u2013Prescribing Information for Health Care Providers and Patient Labeling","author":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)","year":"2004"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/13697130801983921","article-title":"Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause","volume":"11","author":"Birkhauser","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2010.483297","article-title":"Minimized estradiol absorption with ultra-low-dose 10 micrograms 17beta-estradiol vaginal tablets","volume":"13","author":"Eugster-Hausmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5122(92)90246-Z","article-title":"Low-dose oestradiol in the treatment of urogenital oestrogen deficiency\u2014a pharmacokinetic and pharmacodynamic study","volume":"15","author":"Nilsson","year":"1992","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0110","first-page":"556","article-title":"Estradiol absorption from vaginal tablets in postmenopausal women","volume":"99","author":"Notelovitz","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet","volume":"112","author":"Simon","year":"2008","journal-title":"Obstett. Gynecol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0115","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","article-title":"Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women","volume":"90","author":"Simon","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2005.02.019","article-title":"Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004\/2005 position statements on peri- and postmenopausal hormone replacement therapy","volume":"51","author":"Skouby","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2013.08.002_bib0135","first-page":"14","article-title":"DHEA after menopause \u2013 sole source of sex steroids and potential sex steroid deficiency treatment","volume":"19","author":"Labrie","year":"2010","journal-title":"Menopause Manage."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:45:35Z","timestamp":1760744735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076013001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"alternative-id":["S0960076013001453"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.08.002","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}